Hangzhou Huajin Pharmaceutical Co., Ltd

Hangzhou Huajin Pharmaceutical Co., Ltd is one of high-tech pharmaceutical enterprises in provincial level supporting by our country, located in the scenic West Lake----Hangzhou national high-tech industrial development zone. Huajin Pharma founded in 1995. So far this year, we have owned three subsidiary corporations----one of which is production base, other is municipal level technique center occupied by staffs of pharmacy, medicine, biology over 60% of company total workforce. We mainly deal with production of bio-extracting raw material, oral solid formulations, small dose injection, lyophilized powder for injection, pharmaceutical intermediates and no residue biologic drugs for veterinary. Our Main products include in dozens of finished drugs and pharmaceutical raw material as well as intermediate, such as Hepatocyte growth-promoting factors enteric-coated capsules, transfer factor capsules, Cerebrolysin concentrate and etc. Since the beginning of our establishment, we insisted to meet the development of biomedicinesâ?? requests, adhering to the direction of sophistication and specialization, as well as striving to promote innovation and quality standards of biochemical drugs. The hepatocyte growth -promoting factor capsules is new drugs of our country and national exclusive medicine with unique pharmacology, security and good performance in the curative effect of albumin improvement, wining affirmation from national experts of hepatitis diseases. The HGF capsules to be nominated as strongly recommended drug, and it is proceeding well to export abroad; We are also pleased to note the favorable response to our polypeptides biochemical products, owing to products&＃039; high purity, strong activity and security. Being invited to work together with the National Pharmacopoeia Committee for improvement of the partial biochemical quality criterion due to our Cerebrolysin concentrate and HGF higher quality criterion in the country. Meanwhile, some of products are approved by Korean and American companies. Currently, we are on the process of applying for certification of Korean DMF and American FDA, and biochemical products such as thymosin a1, fasudil and so on to be proceeding in applying for drug number. â??Regard medication user as our familyâ?? is our company&＃039;s service motto. We devoted ourselves to our products quality & technical innovation and carrying out cooperation with relevant university and research institutes. For example, University of Science and Technology of China, USTC and Zhejiang University of China. At present, we have gotten 10 patents including productive technology of HGF capsules. Since 2001, Our company has been nominated as "HI-tech Enterprise" by Department of Science and Technology in Zhejiang province. Since 2007, to be awarded the highest rank â??Pharmaceutical enterprise in supervised rank AA" by Hangzhou Food and Drug Administration for many times. At 2009, to be awarded as "Contract credit of Industry and commercial enterprise AA rank corporation in ZhejiangProvince". With "Based on honest and credit, taking business forward "as companyâ??s management conception, our products has been sold not only in the domestic country involved in 30 provinces and cities, but also many foreign countries, such as Korea, German, Vietnam and so on and making sales moved upwards by season. Huajin Pharma owns multiple trademarks, among which â??HJBCâ?? was evaluated as â??Well-known Brandâ?? by Government of Hangzhou. To accelerate the transformation and upgrade the enterprise based on the principles of prior consideration about similar products, economies of scale and products advantages, our company purchased or held three subsidiaries successively in the past few years. These three subsidiaries manufacturing small dose injections, lyophilized powder injection, pharmaceutical intermediate and no residues bio-tech drugs for veterinary including lyophilized powder injection for veterinary. Currently, applications for GMP certification and preparation number are being finished, and will proceed to manufacture.